Loading...
The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0
(1) Background: Fingolimod (Gilenya(®)) was the first oral treatment for patients with relapsing-remitting multiple sclerosis (RRMS). Since its approval, the treatment landscape has changed enormously. (2) Methods: Data of PANGAEA and PANGAEA 2.0, two German real-world studies, were descriptively an...
Na minha lista:
| Udgivet i: | J Pers Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8233755/ https://ncbi.nlm.nih.gov/pubmed/34208513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11060561 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|